公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2021 | Efficacy and prognosis of first-line egfr-tyrosine kinase inhibitor treatment in older adults including poor performance status patients with egfr-mutated non-small-cell lung cancer | Chang C.-Y.; CHUNG-YU CHEN ; Chang S.-C.; Lai Y.-C.; Wei Y.-F. | Cancer Management and Research | 7 | 7 | |
2021 | Epigenome-wide association study on asthma and chronic obstructive pulmonary disease overlap reveals aberrant DNA methylations related to clinical phenotypes | Chen Y.-C.; Tsai Y.-H.; Wang C.-C.; Liu S.-F.; Chen T.-W.; Fang W.-F.; Lee C.-P.; Hsu P.-Y.; Chao T.-Y.; Wu C.-C.; Wei Y.-F.; Chang H.-C.; Tsen C.-C.; Chang Y.-P.; Lin M.-C.; CHONG-JEN YU ; HAO-CHIEN WANG ; Chiang C.-H.; Perng D.-W.; Cheng S.-L.; Hsu J.-Y.; Hsu W.-H.; Hsiue T.-R.; Lin H.-I.; Wang C.-Y.; YEUN-CHUNG CHANG ; Chen C.-M.; Lin C.-S.; Chen L.; Chong I.-W.; Taiwan Clinical Trial Consortium of Respiratory Disease (TCORE) group | Scientific Reports | 16 | 12 | |
2019 | Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study | Wei Y.-F.; Huang W.-T.; Liu T.-C.; Shieh J.-M.; Chian C.-F.; Wu M.-F.; Chang C.-C.; Lin C.-H.; JEN-CHUNG KO ; Lin C.-M.; Hsia T.-C. | Journal of Cancer | 7 | 6 | |
2015 | Factors associated with the prescription of inhaled corticosteroids in GOLD group A and B patients with COPD – Subgroup analysis of the Taiwan obstructive lung disease cohort | Wei Y.-F.; PING-HUNG KUO ; Tsai Y.-H.; Tao C.-W.; Cheng S.-L.; Lee C.-H.; Wu Y.-K.; Chen N.-H.; Hsu W.-H.; Hsu J.-Y.; Lin M.-S.; Wang C.-C. | International Journal of COPD | 12 | 11 | |
2016 | Factors responsible for poor sleep quality in patients with chronic obstructive pulmonary disease | Chang C.-H.; Chuang L.-P.; Lin S.-W.; Lee C.-S.; Tsai Y.-H.; Wei Y.-F.; Cheng S.-L.; Hsu J.-Y.; PING-HUNG KUO ; CHONG-JEN YU ; Chen N.-H. | BMC Pulmonary Medicine | 35 | 31 | |
2015 | Features of COPD patients by comparing CAT with mMRC: A retrospective, cross-sectional study | Huang W.-C.; Wu M.-F.; Chen H.-C.; Hsu J.-Y.; Tsai Y.-H.; Tao C.-W.; Cheng S.-L.; Lee C.-H.; PING-HUNG KUO ; Wu Y.-K.; Chen N.-H.; Hsu W.-H.; Hsu J.-Y.; Lin M.-S.; Wang C.-C.; Wei Y.-F.; TOLD Group | npj Primary Care Respiratory Medicine | 29 | 21 | |
2015 | Glossogyne tenuifolia extract inhibits TNF-α-induced expression of adhesion molecules in human umbilical vein endothelial cells via blocking the NF-κB signaling pathway | Hsuan C.-F.; Hsu H.-F.; Tseng W.-K.; Lee T.-L.; Wei Y.-F.; Hsu K.-L.; CHAU-CHUNG WU ; Houng J.-Y. | Molecules | 31 | 31 | |
2011 | Imaging patterns and prognosis of patients with gefitinib-related interstitial lung disease | Yuan M.-K.; Chang C.-Y.; Chang S.-C.; Chang S.-J.; Tang G.-J.; Wei Y.-F.; Liu Y.-C.; Chen C.-Y.; CHONG-JEN YU | International Journal of Clinical Pharmacology and Therapeutics | 4 | 3 | |
2018 | The impact of 2011 and 2017 Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) guidelines on allocation and pharmacological management of patients with COPD in Taiwan: Taiwan Obstructive Lung Disease (TOLD) study | Hsieh M.-J.; Huang S.-Y.; Yang T.-M.; Tao C.-W.; Cheng S.-L.; Lee C.-H.; PING-HUNG KUO ; Wu Y.-K.; Chen N.-H.; Hsu W.-H.; Hsu J.-Y.; Lin M.-S.; Wang C.-C.; Wei Y.-F.; Tsai Y.-H. | International Journal of COPD | 20 | 20 | |
2021 | Impact of chronic obstructive pulmonary disease on the mortality of patients with small cell lung cancer | Liao K.-M.; Hung C.-M.; CHIN-CHUNG SHU ; Lee H.-S.; Wei Y.-F. | International Journal of COPD | 5 | 3 | |
2014 | The impact of metabolic parameters on the change of pulmonary function in obese patients | Wei Y.-F.; HUEY-DONG WU ; Yung-Chieh Yen P.D.; Huang C.-K.; Tai C.-M.; Hsuan C.-F. | Surgery for Obesity and Related Diseases | 12 | 11 | |
2017 | Impact of overweight and obesity on acute exacerbations of COPD - Subgroup analysis of the Taiwan obstructive llung disease cohort | Wei Y.-F.; Tsai Y.-H.; Wang C.-C.; PING-HUNG KUO ; On behalf of the TOLD Study Group | International Journal of COPD | 32 | 32 | |
2010 | The impact of various anthropometric measurements of obesity on pulmonary function in candidates for surgery | Wei Y.-F.; HUEY-DONG WU ; Chang C.-Y.; Huang C.-K.; Tai C.-M.; Hung C.-M.; Tseng W.-K.; CHAU-CHUNG WU | Obesity Surgery | 27 | 25 | |
2020 | The impact on incident tuberculosis by kidney function impairment status: Analysis of severity relationship | CHIN-CHUNG SHU ; Wei Y.-F.; Yeh Y.-C.; HSIEN-HO LIN ; CHUNG-YU CHEN ; Wang P.-H.; Cheng S.-L.; JANN-YUAN WANG ; CHONG-JEN YU | Respiratory Research | 9 | 9 | |
2019 | Intracranial Responses to Afatinib at Different Doses in Patients With EGFR-mutated Non–small-cell Lung Carcinoma and Brain Metastases | Wei Y.-F.; Lim C.-K.; Tsai M.-S.; Huang M.-S.; KUAN-YU CHEN | Clinical Lung Cancer | 16 | 13 | |
2021 | PD-L1 expression and outcome in patients with metastatic non-small cell lung cancer and EGFR mutations receiving EGFR-TKI as frontline treatment | Chang C.-Y.; Lai Y.-C.; Wei Y.-F.; CHUNG-YU CHEN ; Chang S.-C. | OncoTargets and Therapy | 6 | 6 | |
2022 | Plasma Concentrations of sTREM-1 as Markers for Systemic Adverse Reactions in Subjects Treated With Weekly Rifapentine and Isoniazid for Latent Tuberculosis Infection | Wang T.-Y.; Feng J.-Y.; CHIN-CHUNG SHU ; Lee S.S.-J.; CHUNG-YU CHEN ; Wei Y.-F.; Lin C.-B.; Huang W.-C.; Su W.-J.; Lin S.-M. | Frontiers in Microbiology | 3 | 2 | |
2022 | Prevalence of Latent Tuberculous Infection in Patients with Nontuberculous Mycobacterial Lung Disease and Colonization: A Prospective Study in an Intermediate Tuberculosis Burden Country | Lee H.-S.; Wei Y.-F.; Tsai Y.-J.; Wang P.-H.; CHUNG-YU CHEN ; Pan S.-W.; CHIN-CHUNG SHU | Open Forum Infectious Diseases | 1 | 1 | |
2007 | Pulmonary infarction from central venous air embolism mimicking round pneumonia | SHIH-CHI KU ; Wei Y.-F.; Lin, Lung-Chun | Thorax | 3 | 3 | |
2019 | Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial | Nakagawa K.; Garon E.B.; Seto T.; Nishio M.; Ponce Aix S.; Paz-Ares L.; Chiu C.-H.; Park K.; Novello S.; Nadal E.; Imamura F.; Yoh K.; JIN-YUAN SHIH ; Au K.H.; Moro-Sibilot D.; Enatsu S.; Zimmermann A.; Frimodt-Moller B.; Visseren-Grul C.; Reck M.; Chu Q.; Cortot A.; Pujol J.-L.; Fabre E.; Lamour C.; Bischoff H.; Kollmeier J.; Kimmich M.; Engel-Riedel W.; Hammerschmidt S.; Schütte W.; Syrigos K.; Ho J.C.M.; Au K.-H.; Ardizzoni A.; Pasello G.; Gregorc V.; Del Conte A.; Galetta D.; Takahashi T.; Kumagai T.; Hotta K.; Goto Y.; Hosomi Y.; Sakai H.; Takiguchi Y.; Kim Y.H.; Kurata T.; Yamaguchi H.; Daga H.; Okamoto I.; Satouchi M.; Ikeda S.; Kasahara K.; Atagi S.; Azuma K.; Aoe K.; Horio Y.; Yamamoto N.; Tanaka H.; Watanabe S.; Nogami N.; Ozaki T.; Koyama R.; Hirashima T.; Kaneda H.; Tomii K.; Fujita Y.; Seike M.; Nishimura N.; Kato T.; Ichiki M.; Saka H.; Hirano K.; Nakahara Y.; Sugawara S.; Kim S.-W.; Min Y.J.; Lee H.W.; Kang J.-H.; An H.J.; Lee K.H.; Kim J.-S.; Lee G.-W.; Lee S.Y.; Alexandru A.; Udrea A.A.; Juan-Vidal Ó.; Nadal-Alforja E.; Gil-Bazo I.; Ponce-Aix S.; Rubio-Viqueira B.; Alonso Garcia M.; Felip Font E.; Fuentes Pradera J.; Coves Sarto J.; Lin M.-C.; Su W.-C.; Hsia T.-C.; Chang G.-C.; Wei Y.-F.; Su J.; Cicin I.; Goksel T.; Harputluoglu H.; Ozyilkan O.; Henning I.; Popat S.; Hatcher O.; Mileham K.; Acoba J.; Garon E.; Jung G.; Raj M.; Martin W.; Dakhil S. | The Lancet Oncology | 397 | 341 |